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Persistent viral infections and tumors drive develop-
ment of exhausted T (TEX) cells. In these settings,
TEX cells establish an important host-pathogen or
host-tumor stalemate. However, TEX cells erode
over time, leading to loss of pathogen or cancer
containment. We identified microRNA (miR)-155 as
a key regulator of sustained TEX cell responses
during chronic lymphocytic choriomeningitis virus
(LCMV) infection. Genetic deficiency of miR-155 ab-
lated CD8 T cell responses during chronic infection.
Conversely, enhanced miR-155 expression pro-
moted expansion and long-term persistence of TEX
cells. However, rather than strictly antagonizing
exhaustion, miR-155 promoted a terminal TEX cell
subset. Transcriptional profiling identified coordi-
nated control of cell signaling and transcription fac-
tor pathways, including the key AP-1 family member
Fosl2. Overexpression of Fosl2 reversed the miR-
155 effects, identifying a link between miR-155 and
the AP-1 transcriptional program in regulating TEX
cells. Thus, we identify a mechanism of miR-155
regulation of TEX cells and a key role for Fosl2 in
T cell exhaustion.
INTRODUCTION
Persistent infections and tumors result in the development of
dysfunctional T cells, a process driven by chronic antigen stimu-
lation and unresolved inflammation. This T cell exhaustion
is characterized by increased expression of inhibitory mole-
cules, reduced cytokine production, an altered transcriptional
program, metabolic changes, and failure to persist long-term
(Wherry et al., 2003; Wherry and Kurachi, 2015). Although ex-
hausted T (TEX) cells have suboptimal function compared with
effector T (TEFF) andmemory T (TMEM) cells, TEX cells often estab-
lish a host pathogen or host tumor stalemate, partially controlling
the pathogen or tumor and/or driving immune selection of viral or2142 Cell Reports 23, 2142–2156, May 15, 2018 ª 2018 The Authors
This is an open access article under the CC BY license (http://creativetumor variants (Wherry and Kurachi, 2015; Jamieson et al., 2003;
Paley et al., 2012). However, in prolonged chronic infections in
mice (Wherry et al., 2003; Zajac et al., 1998) and humans
(Bengsch et al., 2010; Day et al., 2006; Gruener et al., 2001),
TEX cells can quantitatively and qualitatively erode over time,
leading to loss of pathogen or tumor containment. Thus, under-
standing the pathways that underlie the durability and sustain-
ability of TEX cells could have important implications for contain-
ing or controlling persistent intracellular pathogens and cancer.
During chronic infections, TEX cells lose proliferative potential
and respond poorly to memory self-renewal signals like inter-
leukin-7 (IL-7) and IL-15 (Shin et al., 2007). Human data also
support the notion that the durability of TEX cells may be compro-
mised during chronic infections. Therapies (such as antiretroviral
therapy for HIV) may increase the proliferative potential of TEX
cells; however the half-life of these cells remains substantially
reduced compared with healthy CD8 T cells (Hellerstein et al.,
1999), demonstrating a pervasive effect on the durability of
T cells generated during chronic infection. Similarly, for hepatitis
C virus (HCV), prolonged infection is associated with an inability
to sustain virus-specific CD8 T cells (Lechner et al., 2000).
Checkpoint blockade targeting inhibitory receptor pathways
such as PD-1 can reinvigorate TEX cells (Barber et al., 2006),
providing considerable benefits in chronic infection (Trautmann
et al., 2006; Velu et al., 2009) and in cancer patients (Brahmer
et al., 2012; Topalian et al., 2012). However, recent studies
have demonstrated that checkpoint blockade alone does not
necessarily improve the durability of ‘‘reinvigorated’’ TEX cells
(Pauken et al., 2016). These observations are consistent with
the lack of long-term clinical benefits in many patients upon
administration of checkpoint inhibitor blockade (Pauken and
Wherry, 2015; Sharma and Allison, 2015). Moreover, prolonged
chronic infection leads to progressive erosion of TEX cell popula-
tions (Paley et al., 2012), and the response to PD-1 blockade also
declines over time (Penaloza-MacMaster et al., 2015), indicating
a poor ability to sustain TEX cell responses. Thus, understanding
the pathways regulating the durability of TEX cells and developing
strategies to enhance their persistence could aid in disease
control.
We have previously defined subsets of TEX cells based on
expression of inhibitory receptors (Blackburn et al., 2009) or.
commons.org/licenses/by/4.0/).
the transcription factors T-bet and Eomes (Paley et al., 2012).
These data indicate that the TEX cell population is maintained
by a proliferative hierarchy of two interrelated subsets. A progen-
itor subset exists that, in the presence of persisting antigen,
gives rise through extensive proliferation to a terminal PD-1Hi
subset (Paley et al., 2012). Recent studies have also described
subsets based on CXCR5 and TCF-1 expression, with TCF-1
playing a key role in the progenitor subset (He et al., 2016; Im
et al., 2016; Leong et al., 2016; Utzschneider et al., 2016; Wu
et al., 2016). The terminal EomesHi PD-1Hi subset of TEX cells
has a short half-life in vivo, suggesting constant repopulation
from the progenitor pool, but the maintenance of this population
remains poorly understood. Both subsets are essential to main-
tain control of chronic infections (Paley et al., 2012). Because the
terminal subset of TEX cells is numerically more abundant, under-
standing the mechanisms that maintain this population could aid
in developing strategies for control of persisting infections and
tumors.
Recent studies have focused on the role of inhibitory recep-
tors, cytokine signaling pathways, transcriptional networks,
and metabolic changes that regulate TEX cells (Wherry and Kur-
achi, 2015). The role of non-coding RNAs, however, remains
largely unknown. MicroRNAs (miRNAs) regulate many aspects
of immune system biology and T cell responses (Mehta and Bal-
timore, 2016). These small non-coding RNAs can simultaneously
downregulate several mRNA targets based on complementarity
and, therefore, have a prominent effect on a wide range of bio-
logical functions. However, the selective transcription of mRNAs
in different cell types results in different availability of target
mRNAs. As a result, miRNAs can have diverse effects based
on the cell type and cell state examined (Lu et al., 2015). Although
there has been considerable effort to understand the role of spe-
cific miRNAs in the immune system and, to a lesser extent, in
T cells (Moffett et al., 2017), there is little information about the
role of specific miRs in TEX cells.
miR-155 has a well-documented role in regulating T cell re-
sponses (Lind and Ohashi, 2014). miR-155 enhances CD8
T cell expansion during acute infections and cancer (Gracias
et al., 2013; Lind et al., 2013; Lind and Ohashi, 2014; Tsai
et al., 2013) and regulates responses to inflammatory and cyto-
kine signals in different settings, such as acutely resolved viral
and bacterial infections (Gracias et al., 2013), tumor models (Ji
et al., 2015), autoimmunity (O’Connell et al., 2010), and age-
dependent inflammation (Hu et al., 2014). Expression of miR-
155 is increased in HIV infection, and higher expression of
miR-155 correlates with increased disease (Witwer et al.,
2012). Despite this previous work, it is unclear whether miR-
155 has a role in TEX cells during chronic infections and, if so,
how miR-155 functions in this setting.
In this study, we investigated whether miR-155 affects CD8
T cell responses to chronic infection and specifically interrogated
how miR-155 affects the differentiation of TEX cells. Using T cell
adoptive transfers, we demonstrated that genetic deletion of
miR-155 reduced CD8 T cell expansion during chronic infection
in a dose-dependent manner. In contrast, overexpression of
miR-155 in virus-specific CD8 T cells enhanced expansion and
long-term persistence during chronic lymphocytic choriomenin-
gitis virus (LCMV) infection. However, this effect during chronicinfection was not because miR-155 antagonized exhaustion;
rather, miR-155 fostered the development, accumulation, and
long-term durability of a large population of terminally differ-
entiated PD-1HiEomesHi TEX cells. Transcriptional profiling re-
vealed several pathways involved in cell differentiation, prolifer-
ation, chemotaxis, inflammation, and transcriptional regulation
affected by miR-155, including the AP-1 transcription factor
pathway. We further demonstrated that the effect of miR-155
on CD8 T cells in chronic infection was reversed by overexpres-
sion of the AP-1 family transcription factor Fosl2, demonstrating
a key mechanistic link between miR-155 and antagonism of
Fosl2 in controlling the accumulation and persistence of terminal
TEX cells. Thus, these data support a role for miR-155 in TEX cells
through regulation of the AP-1 transcriptional pathway and iden-
tify Fosl2 as a key AP-1 family member in exhausted CD8 T cells.
RESULTS
miR-155 Expression Is Elevated in TEX Cells during
Chronic Viral Infection
We have previously shown that absence of miR-155 is detri-
mental to effector CD8 T cell responses during acute infections
(Gracias et al., 2013). Here we investigated the role of miR-155
in chronic LCMV infection. We first examined the expression of
miR-155 in LCMV-specific CD8 T cells during the development
of exhaustion following persisting infection with LCMV clone 13.
To this end, we adoptively transferred T cell receptor (TCR)
transgenic CD8 T cells specific for the immunodominant LCMV
Db-gp33-41 epitope (P14 cells) to congenically distinct naive
recipient mice and infected these mice with LCMV clone 13
(Figure S1A). Donor P14 CD8 T cells were sorted, and miR-155
expression was examined by qRT-PCR. Expression of miR-
155was increased30-fold in P14CD8 T cells 8 days post infec-
tion (d.p.i.) compared with naive CD8 T cells (Figure S1B), similar
to what was observed previously in acute infection (Gracias
et al., 2013). However, unlike acute infections, where miR-155
expression declines in memory CD8 T cells (Gracias et al.,
2013), miR-155 expression remained elevated 22 and 35 d.p.i.
(Figure S1B). These observations suggested a role for miR-155
in developing TEX cells during chronic viral infection. PD-1
Int
and PD-1Hi subsets of TEX cells were sorted 22 d.p.i. PD-1
Hi ter-
minal TEX cells expressed approximately twice asmuchmiR-155
as the PD-1Int progenitor subset (Figure S1B). Thus, miR-155
was highly expressed in TEX cells and associated with more ter-
minal exhaustion.
miR-155 Expression Is Essential for CD8 T Cell
Responses during Chronic Viral Infection
To interrogate whether miR-155 regulated TEX cell differentia-
tion, we adoptively transferred congenically marked wild-type
(WT), miR-155-haplodeficient (heterozygous [HET]), and miR-
155-deficient (knockout [KO]) P14 cells into wild-type recipients
and analyzed their response to LCMV clone 13 infection (Fig-
ure 1A). miR-155 deficiency conferred a dose-dependent defect
on CD8 T cell expansion upon clone 13 infection (Figure 1B),
consistent with the role of miR-155 in the expansion of CD8
T cells during acute viral and bacterial infections (Gracias et al.,
2013; Lind and Ohashi, 2014; Tsai et al., 2013).Cell Reports 23, 2142–2156, May 15, 2018 2143
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Figure 1. miR-155 Is Essential for the Expansion of CD8 T Cells during Chronic Infection
103 CD8 T cells from naive wild-type (WT, n = 12), miR-155 heterozygous (HET, n = 13), or miR-155-deficient (KO, n = 15) P14 CD45.1+ mice were adoptively
transferred into congenically distinct CD45.2+ recipient mice, followed by infection with LCMV clone 13.
(A) Experimental design.
(B) Donor P14 cells were analyzed in peripheral blood at 9 d.p.i. ***p < 0.001; one-way ANOVA with Tukey’s multiple comparisons test.
(C) The phenotype of donor P14 cells (gated on CD45.1+) was analyzed in blood 9 d.p.i. Significance was calculated with unpaired t test.
Each data point represents an individual mouse. Representative results of two independent experiments are shown. The error bars represent the SEM.Persistent infections result in the generation of TEX cells that
are defined in part by high expression of inhibitory receptors
(Blackburn et al., 2009). Therefore, we asked whether miR-155
deficiency altered the expression of inhibitory receptors on
developing TEX cells. Because of the dramatically reduced
numbers of surviving P14 cells in the absence of miR-155 (KO;
Figure 1B), we investigated the phenotype of heterozygous
(HET) P14 cells. Reduced miR-155 was associated with
decreased expression of PD-1 and CD160 (Figure 1C) on adop-
tively transferred P14 CD8 T cells. Expression of these inhibitory
receptors on the host (WT) CD8 T cells was indistinguishable be-
tween the two groups (Figure 1C). These results suggest a CD8
T cell-intrinsic role for miR-155 in promoting exhaustion of CD8
T cells.
miR-155 Overexpression Results in Enhanced
Expansion and Long-Term Persistence of CD8 T Cells
during Chronic Viral Infection
The decreased CD8 T cell expansion in the absence of miR-155
(Figure 1) suggested that forced expression of miR-155 could
promote CD8 T cell responses to a chronic infection. To test2144 Cell Reports 23, 2142–2156, May 15, 2018this idea, we transduced P14 cells with a retrovirus (RV) vector
(MIGR1-GFP) expressing miR-155 and GFP (miR-155 overex-
pression [OE]) or with an empty MIGR1-GFP vector (control).
Transduced P14 CD8 T cells were adoptively transferred into
congenically marked recipient mice, followed by infection with
clone 13 (Figure 2A). Despite equal transduction efficiency for
control andmiR-155 OE-transduced cells (Figure 2B), expansion
of miR-155 OE cells was significantly greater in both lymphoid
(Figures 2C and 2D) and non-lymphoid (Figure S2) tissues. This
increased numerical accumulation of miR-155 OE cells was
prolonged beyond the first week of infection, and numbers
continued to increase between days 9–15, whereas the number
of control-transduced cells had begun to decline by day 15. This
enhanced expansion also correlatedwithmoremiR-155OE cells
35 d.p.i. (Figures 2C and 2D; Figure S2). Notably, GFP (i.e.,
non-transduced) P14 cells were numerically similar between
the miR-155 and control groups (Figure 2D). Thus, enforced
expression of miR-155 enhanced and prolonged the expansion
of antigen-specific CD8 T cells during chronic viral infection.
To investigate how miR-155 affected the long-term durability
of CD8 T cells, we examined the persistence of the transduced
AB C
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Figure 2. miR-155 Enhances and Prolongs the Expansion of CD8 T Cells during Chronic Viral Infection
CD8 T cells were purified from the spleens of congenically marked (CD45.1) P14 mice, transduced with control (ctrl)-GFP RV or miR-155 OE-GFP RV (miR), and
adoptively transferred to CD45.2+ recipient mice that were infected 24 hr earlier with LCMV clone 13.
(A) Experimental design.
(B) Transduction efficiency was measured after culturing the CD8 T cells in vitro for 24 hr post-transduction. Representative plots show GFP expression on CD8
T cells.
(C) Spleens of recipient mice were isolated 9, 15, and 35 d.p.i., and transduced donor cells were identified based on CD45.1 and GFP expression.
(D) Absolute number of transferred GFP+ P14 cells, total donor P14 cells, and GFP P14 cells were determined in spleens of recipient mice 9, 15, and 35 d.p.i.
****p < 0.0001, *p < 0.05; significance was calculated by two-way ANOVA.
(E) Absolute numbers of GFP+ donor P14 cells determined in spleens of recipient mice 60 (n = 10), 90 (n > 12), and 150 (n > 11) d.p.i. Significance was calculated
by Mann-Whitney test.
Each data point represents an individual mouse. Shown are representative results of at least two independent experiments with a total of at least 10 mice per
group. The error bars represent the SEM.
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CD8 T cells long-term. Overexpression of miR-155 resulted in
significantly higher numbers of transduced CD8 T cells 60, 90,
and 150 d.p.i. (Figure 2E). There was only a minimal decline in
the number of transduced CD8 T cells from 1–5 months post
infection (Figure 2E), suggesting that miR-155 overexpression
not only enhanced expansion but also robustly sustained the
persistence of virus-specific CD8 T cells during chronic viral
infection, with 50- to 100-fold more miR-155-transduced cells
present on day 150 compared with control RV-transduced cells.
miR-155 Overexpression Correlates with Higher
Expression of Inhibitory Receptors on CD8 T Cells
during Chronic Viral Infection
To investigate whether miR-155 altered exhaustion, we analyzed
the phenotype of miR-155 OE CD8 T cells compared with con-
trol-transduced cells. miR-155 OE led to a progressive increase
in the expression of inhibitory receptors (PD-1, CD160, and 2B4)
in the spleen (Figure 3A), liver (Figure S3A), and bone marrow
(Figure S3B). Furthermore, co-expression of multiple inhibitory
receptors was increased in miR-155 OE CD8 T cells (Figure 3B),
suggesting a greater number of cells in the terminally exhausted
subset driven by miR-155. These differences in inhibitory recep-
tor expression were also apparent when comparing miR-155 OE
(GFP+) CD8 T cells with non-transduced (GFP) CD8 T cells
within the same recipients (Figure S4A), excluding environmental
differences because of inflammation and/or viral load. Moreover,
there were no detectable differences in the viral loads between
the two groups of recipient mice 30 d.p.i. (data not shown), likely
because of the small numbers of adoptively transferred P14 cells
used in this system to avoid immunopathology, altered viral con-
trol, or viral escape (Blattman et al., 2009; Frebel et al., 2012;
Odorizzi et al., 2015). Thus, these data identify a cell-intrinsic
role for miR-155 in regulating the differentiation of TEX cells. To
confirm that the effects of miR-155 on CD8 T cell expansion
and differentiation were not dependent on the number of trans-
ferred P14 cells and/or non-transduced GFP cells that were
co-transferred with the transduced GFP+ cells, we sorted and
adoptively transferred different numbers of transduced GFP+
P14 cells. The effects of miR-155 on the expansion (Figure S5A)
as well as the phenotype (Figure S5B) of the transferred cells
were independent of the number of sorted GFP+ cells trans-
ferred. Overall, these data indicate that miR-155 sustained
high numbers of TEX cells expressing multiple inhibitory recep-
tors in chronic infection.
Altered Function of CD8 T Cells because of
Overexpression of miR-155
TEX cells are characterized by poor function. Specifically, a pro-
genitor pool of TEX cells has moderate cytokine production but
weak cytotoxicity. In contrast, a terminal TEX cell population is
less efficient in producing interferon g (IFN-g) and tumor necrosis
factor (TNF) but has slightly elevated cytotoxic potential (Paley
et al., 2012). We next investigated whether miR-155 affects
effector functions of CD8 T cells during chronic viral infection.
miR-155 overexpression reduced the percentages of IFN-g-
and TNF-producing CD8 T cells (Figure 3C). The reduction in
cytokine production started with a significant decrease in
IFN-g 15 d.p.i. and progressed with lower TNF production by2146 Cell Reports 23, 2142–2156, May 15, 201835 d.p.i. (data not shown), consistent with a progressive pheno-
type of exhaustion. However, because of the increased number
of miR-155 OEGFP+ cells, the absolute number of cytokine-pro-
ducing GFP+ cells was increased in miR-155 OE compared with
control-transduced cells (Figure S4B). In contrast, miR-155
increased the production of MIP-1a, granzyme B (GzmB; Fig-
ure 3D), and degranulation, based on CD107a staining (Fig-
ure 3E). These results suggested that miR-155 fostered the
development of cells with a functional profile more similar to
terminally exhausted TEX cells.
miR-155 Promotes and Sustains TEX Cells in the
Absence of CD4 T Cell Help
Depletion of CD4 T cells results in sustained viremia and more
severe CD8 T cell exhaustion following clone 13 infection (Mat-
loubian et al., 1994). This prolonged high viral load can erode
the TEX cell population over time, reminiscent of poorly sustained
T cell responses in humans with uncontrolled long-term HCV or
HIV infection (Hellerstein et al., 1999; Lechner et al., 2000). To
test whether miR-155 altered TEX cell differentiation in this
setting, recipient mice were depleted of CD4 T cells before clone
13 infection, resulting in sustained viremia. miR-155 OE cells
persisted at 40-fold higher numbers compared with control-
transduced cells in CD4 depleted (DCD4) mice, and this advan-
tage of miR-155 OE cells persisted through at least 90 d.p.i. (Fig-
ure 4A). Moreover, miR-155 expression again fostered higher
expression of inhibitory receptors and reduced expression of
effector-associated (KLRG1) and memory-associated (IL-7Ra)
molecules in both CD4-sufficient and DCD4 recipients (Fig-
ure 4B). Thus, miR-155 promotes the development of a large
number of terminally exhausted CD8 T cells that was sustained
long-term even in DCD4 recipients with a high viral load.
miR-155 Enhances TEX Cell Proliferation and the
Terminal TEX Cell Subset while Preserving the
Progenitor Pool Long-Term
BecausemiR-155 expression affected TEX cell differentiation, we
next examined the expression of T-bet and Eomes (Paley et al.,
2012) as well as TCF-1 (He et al., 2016; Im et al., 2016; Leong
et al., 2016; Utzschneider et al., 2016; Wu et al., 2016), which
have been implicated in TEX cell subset differentiation. TEX cell
populations persist because of a proliferative hierarchy where
PD-1Int T-betHi progenitor cells proliferate and generate termi-
nally differentiated PD-1Hi EomesHi cells (Paley et al., 2012). A
role for TCF-1 in this process is now also appreciated. Given
the significant increase in persisting TEX cells upon miR-155
overexpression, we asked whether this was a result of a larger
T-betHi or TCF-1+ progenitor pool because of increased prolifer-
ation of PD-1 and/or T-bet defined subsets or as a result of
increased persistence of the terminally differentiated PD-1Hi
EomesHi subset. miR-155 overexpression reduced the expres-
sion of TCF-1 and the progenitor TCF-1+Tim-3 and TCF-
1+Ly108+ pool (Figure S4C). Similarly, miR-155 OE cells
contained only a small proportion of T-betHi cells and mainly
consisted of PD-1Hi EomesHi cells (Figure 5A), in agreement
with the exhausted phenotype described above. However,
because of the significantly increased total numbers of miR-
155 OE cells, the absolute number of T-betHi cells was greater
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than in the control-transduced population (Figure 5A). We next
asked whether miR-155 altered proliferation. The percentage
and number of Ki67+ T-betHi progenitor TEX subset cells were
not altered by miR-155 overexpression (Figure 5B). In contrast,
miR-155 enhanced the number of Ki-67+ EomesHi cells (Fig-
ure 5B). These observations are consistent with the notion that
miR-155 increases the generation and/or survival of terminally
differentiated EomesHi cells without altering the proliferation of
the progenitor T-betHi pool.
Because inhibitors of the PD-1 pathway can reinvigorate TEX
cells by inducing proliferation of progenitor TEX cells, which re-
sults in accumulation of terminally differentiated cells (Blackburn
et al., 2008; He et al., 2016; Im et al., 2016; Leong et al., 2016;
Huang et al., 2017), we tested whether miR-155 OE enhanced
the benefit of anti-PDL1 treatment during chronic LCMV infec-
tion. Recipients of miR-155 OE and control P14 cells were
treated with anti-PDL1 blocking antibody 22–35 d.p.i. As ex-
pected, in anti-PDL1-treated mice, control-transduced P14 cells
showed a trend for increased numbers (p = 0.1) and had lower
inhibitory receptor and increased KLRG1 expression compared
with P14 cells fromPBS-treatedmice (Figure S4D). However, the
phenotype of miR-155 OE cells was not significantly altered
upon anti-PDL1 treatment (Figure S4D). Although it is possible
that longer treatmentmay benefitmiR-155OE cells or that a local
benefit in effector functions occurs, these data suggest that miR-
155 OE does not significantly complement the benefit of anti-
PDL1 treatments.
Major Transcriptional Changes in TEX Cells because of
miR-155 OE
To investigate how miR-155 affects the expansion and differen-
tiation of CD8 T cells during chronic infection, we performed a
transcriptome analysis. Recipients of miR-155 OE or control-
transduced cells were infected with clone 13. 30 d.p.i., trans-
duced GFP+ P14 cells as well as co-transferred non-transduced
GFP- P14 cells were sorted by flow cytometry, and RNA
sequencing (RNA-seq) was performed (Figure 6A). GFP+ cells
from the control group and GFP cells from both the control
and the miR-155 OE groups served as controls to exclude tran-
scripts that were differentially expressed either because of
extrinsic factors (i.e., the environment) or because of the different
activation status of the cells at the time of transduction (GFP+
versus GFP). Pairwise comparisons identified 395 transcripts
differentially expressed in miR-155 OE cells with p < 0.05 (Fig-Figure 3. miR-155 Promotes the Phenotype of Exhaustion on CD8 T C
CD45.1+ P14 CD8 T cells were transduced with either control-GFP RV or miR-15
were infected 24 hr earlier with LCMV clone 13.
(A) Expression of the inhibitory receptors PD-1 (n > 10), CD160 (n > 10), and 2B4 (n
15, and 35 d.p.i. Significance was calculated by unpaired t test.
(B) Co-expression of PD-1 and CD160 (left) and PD-1 and 2B4 (right) on donor G
individual mouse. Representative results of at least two independent experiments
or unpaired t test (PD-1+2B4+).
(C) Production of IFN-g and TNF by donor GFP+ CD8 T cells was measured by fl
(D) Production of MIP-1a (n > 12) and GzmB (n > 8) by donor GFP+ CD8 T cells wa
(E) Degranulation was measured by staining for CD107a. Black lines, control tr
unstimulated control. Significance was calculated by Mann-Whitney test (n > 12
Representative plots are gated on GFP+ CD45.1+ CD8 T cells. Each data point
pendent experiments are shown. The error bars represent the SEM.
2148 Cell Reports 23, 2142–2156, May 15, 2018ure 6B). Among the 200 transcripts downregulated in miR-155
OE cells, 12 transcripts (Figure 6B) were predicted targets of
miR-155 (TargetScan version 7.1). These transcriptionally down-
regulated miR-155 targets represent 3.4% of all predicted miR-
155 targets in our dataset (12 of 354 miR-155 target genes).
Because only 1.9% of all transcripts (200 of 10,297 genes)
were downregulated in miR-155 OE cells (Figure 6B), this repre-
sents a significant enrichment for miR-155 targets being down-
regulated in miR-155 OE cells (p value of overlap = 0.03). There-
fore, we hypothesized that the effect of miR-155 on CD8 T cells
responding to chronic infection may involve one or more direct
miR-155 targets.
We further investigated the pathways affected bymiR-155 and
found that several pathways related to responses to cytokines
and inflammatory mediators as well as T cell activation were
downregulated by miR-155 (Table S1). Gene set enrichment
analysis (GSEA) confirmed that several cytokine signaling
pathways (TNF, IL-6, IFN-g, and transforming growth factor
b [TGF-b]) were significantly enriched in control-transduced
compared with miR-155 OE cells (Figure 6C; Figure S6A).
Thus, these data support the idea that miR-155 dampens the
response to inflammation, facilitating CD8 T cell persistence in
an environment of high inflammatory stress.
We next asked whether these transcriptional changes
revealed any common upstream regulators that might act as
central ‘‘nodes’’ in the miR-155 effect on TEX cells. Indeed, three
transcription factors, Nfatc2, Foxo1, and Ets1, were predicted to
be negatively regulated based on the expression of their target
genes (Figure S6B). We next constructed a network from the
genes differentially regulated by miR-155. This network revealed
several cytokine and chemokine receptors (Il7r, Tnf, Ccr9, and
Cxcl10) as well as transcription factors (Prdm1, Bcl6, Jun, and
Tcf7) that were differentially regulated by miR-155 (Figure 6D).
These observations suggested that miR-155 regulated TEX cells
during chronic infection by modulating responses to cytokines
and inflammatory mediators with an effect via several key tran-
scriptional pathways.
The Effect of miR-155 on TEX Cell Differentiation Is
Mediated in Part by Targeting the AP-1 Transcription
Factor Fosl2
The transcriptional pathways inhibited by miR-155 overexpres-
sion included several members of the AP-1 pathway, such as
Jun, JunB, FosB, and Fosl2 (Figure 6D; Figure S6B). Amongells during Chronic Viral Infection
5 OE-GFP RV (miR) and adoptively transferred to CD45.2+ recipient mice that
> 8) was analyzed on donor GFP+ CD8 T cells in the spleens of recipient mice 9,
FP+ CD8 T cells in spleens 35 d.p.i. (n > 12). Each data point represents an
are shown. Significance was calculated byMann-Whitney test (PD-1+CD160+)
ow cytometry. Significance was calculated by Mann-Whitney test (n > 12).
s measured by flow cytometry. Significance was calculated by unpaired t test.
ansduced GFP+ P14 cells; red lines, miR-155 OE GFP+ P14 cells; gray line,
).
represents an individual mouse. Representative results of at least three inde-
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Figure 4. miR-155 Promotes a Terminally Exhausted TEX Cell Subset without CD4 T Cell Help during Chronic Viral Infection
CD45.1+ P14 CD8 T cells were transduced with either control-GFP RV or miR-155 OE-GFP RV and adoptively transferred to CD45.2+ recipient mice that were
infected 24 hr earlier with LCMV clone 13 and treated (DCD4) with anti-CD4 or left untreated.
(A) Absolute number of GFP+ donor CD8 T cells in spleens 60 (n = 10) and 90 (n = 9) d.p.i. in mice treated with anti-CD4 (DCD4).
(B) Phenotype of GFP+ donor CD8 T cells in spleens 90 d.p.i.
Representative plots are gated on GFP+ CD45.1+ CD8 T cells. Each data point represents an individual mouse. Significance was calculated by Mann-Whitney
test. Representative results of two independent experiments are shown. The error bars represent the SEM.these, Fosl2 has been previously identified as a direct target of
miR-155. The role of Fosl2 in CD8 TEX cells, however, is un-
known. Therefore, we hypothesized that Fosl2 may play a role
in TEX cell differentiation and that the effect of miR-155 on TEX
cells could be mediated by targeting Fosl2.
To this end, we first investigated the expression of Fosl2 in TEX
cells. Fosl2was expressed in TEX cells, but expression was lower
in terminally exhausted PD-1Hi TEX cells compared with PD-1
Int
TEX cells (Figure S7A). These results suggested a Fosl2 expres-
sion pattern in TEX cell subsets that was anti-correlated withmiR-155. Furthermore, the pathways of the AP-1 transcription
factors Fosl1 and Fosl2 were enriched in the transcriptional
signatures of control versus miR-155 OE GFP+ CD8 T cells (Fig-
ure S7B), supporting the notion that Fosl2 activity was
decreased in the presence of miR-155. We hypothesized that
the downregulation of Fosl2 by miR-155 OE may increase the
activity of nuclear factor activated T cell (NFAT) functioning
without canonical AP-1 dimers (‘‘partnerless NFAT’’) (Martinez
et al., 2015), which induces key TEX cell-associated genes.
Indeed, the signature of genes upregulated by partnerlessCell Reports 23, 2142–2156, May 15, 2018 2149
AB
Figure 5. miR-155 Increases CD8 T Cell Proliferation while Preserving the TEX Cell Progenitor Pool Long-Term
CD45.1+ P14 CD8 T cells were transduced with either control-GFP RV (control) or miR-155 OE-GFP RV and adoptively transferred to CD45.2+ recipient mice that
were infected 24 hr earlier with LCMV clone 13.
(A) Expression of T-bet and Eomes was analyzed on donor GFP+ CD8 T cells in the spleens of recipient mice 35 d.p.i. (n > 20). Representative plots are gated on
GFP+ P14 cells.
(B) Expression of Ki-67 in EomesHi and T-betHi donor GFP+ CD8 T cells was analyzed in the spleens of recipient mice 35 d.p.i. (n > 14). Representative plots are
gated on EomesHi or T-betHi GFP+ P14 cells.
Each data point represents an individual mouse. Representative results of four independent experiments are shown. Significance was calculated by unpaired t test
(for EomesHi cells, normally distributed samples) or Mann-Whitney test (for TbetHi cells, non-normally distributed samples). The error bars represent the SEM.NFAT (Martinez et al., 2015) overlapped with the signature of
genes upregulated in miR-155 OE GFP+ compared with control
GFP+CD8T cells (p value of overlap = 2.643 1010; Figure S7C).
This overlap included genes associated with terminal exhaus-
tion, such as Prdm1, Havcr2, Pdcd1, Cd200r1, and Tigit (Fig-
ure S7C). In addition, the signature of genes downregulated
upon binding of partnerless NFAT overlapped with the signature
of genes downregulated in miR-155 OE GFP+ compared with2150 Cell Reports 23, 2142–2156, May 15, 2018control GFP+ CD8 T cells (p value of overlap = 3.93 3 1010).
These data suggest that miR-155 promotes the transcriptional
program of exhaustion by downregulating the AP-1 transcription
factor Fosl2 and increasing the activity of partnerless NFAT.
To directly test the causal connection between Fosl2, exhaus-
tion, and miR-155, we asked whether overexpression of Fosl2
could reverse the effect of miR-155. We co-transduced P14
CD8 T cells with an miR-155 OE RV (with the GFP reporter)
AB
C
D
(legend on next page)
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and an RV overexpressing Fosl2 (Fosl2-OE RV with the violet
excited protein [VEX] reporter). Because only the coding region
of Fosl2 was introduced, Fosl2 expressed from theRV is not sub-
jected to regulation by miR-155 targeting the Fosl2 30 UTR. P14
cells transduced either with miR-155-GFP or with miR-155-GFP
and control-VEX (empty-VEX [eVEX]) expanded more and ex-
pressed more inhibitory receptors (Figure 7A), in agreement
with the results above. Overexpression of Fosl2 resulted in
greater expansion of transduced P14 cells and decreased co-
expression of CD160 and PD-1 (Figure 7B). These results
demonstrate a role for the AP-1 transcription factor Fosl2 in
TEX cell differentiation.
Because miR-155 represses Fosl2 by directly binding to the
30 UTR (Hu et al., 2014), and expression of Fosl2 was decreased
upon miR-155 overexpression (Figure 6B), we hypothesized that
the miR-155 effect would be reversed by overexpression of
Fosl2. Enforced expression of non-repressible Fosl2 in the pres-
ence of miR-155 OE completely reversed the effect of miR-155
on inhibitory receptor expression and fostered higher IL-7Ra
compared with miR-155-GFP single-transduced cells (Fig-
ure 7C). These results demonstrate that enforced expression of
Fosl2 antagonizes the effect of miR-155, suggesting that inhibi-
tion of the AP-1 pathway is a mechanism by which miR-155
promotes exhaustion and long-term persistence of CD8 T cells
during chronic infection.
DISCUSSION
In this study, we identified a role for miR-155 in regulating CD8
T cell exhaustion during chronic viral infection. miR-155 was
highly expressed by terminally exhausted CD8 T cells during
chronic infection. Enhanced expression of miR-155 promoted
long-term persistence of mainly the terminal TEX cell subset by
preserving the progenitor pool and increasing the generation
and durability of terminally differentiated PD-1Hi EomesHi TEX
cells. miR-155 overexpression induced prominent transcrip-
tional changes in CD8 T cells responding to chronic infection,
affecting several key pathways. Among these, we identified a
connection between miR-155 and the AP-1 transcriptional
pathway in TEX cells through Fosl2.
Transcriptional profiling revealed several pathways altered
because of miR-155 overexpression. These pathways included
key inflammatory circuits as well as TCR signaling molecules.
Although inflammatory cytokines are essential for optimal T cell
priming, persistent inflammation, and particularly type I IFN
signaling during chronic infection, are detrimental for T cell differ-
entiation (Stelekati et al., 2014; Teijaro et al., 2013; Wilson et al.,Figure 6. Overexpression of miR-155 Leads to Major Transcriptional C
CD45.1+ P14 CD8 T cells were transduced with either control-GFP RV or miR-15
infected 24 hr earlier with LCMV clone 13. GFP+ as well as GFP donor P14 CD8
(A) Experimental design.
(B) Heatmap showing the transcripts that were differentially expressed (p < 0.05)
identified by pairwise comparisons using DESeq2. The Venn diagram shows th
predicted targets of miR-155 that were expressed in our dataset.
(C) Enrichment of a gene set of inflammation (HALLMARK_INFLAMMATORY_RE
(D) Network constructed using the 395 transcripts in (B) using IPA. Green represe
represents upregulation.
2152 Cell Reports 23, 2142–2156, May 15, 20182013). We have previously shown that miR-155 tunes the
response of TEFF cells to type I IFN by inhibiting the phosphory-
lation of STAT1 (Gracias et al., 2013). Our transcriptional profiling
here suggests that miR-155 reduces inflammatory cytokine
signaling (TNF, IL-6, IFN-g, and TGF-b) and shields TEX cells
from the detrimental effects of persistent inflammation. On the
other hand, it has been shown that miR-155 enhances the
responsiveness of tumor-specific CD8 T cells to common
g-chain cytokines and subsequent phosphorylation of STAT5
(Ji et al., 2015), suggesting that multiple context-dependent
mechanisms may exist for miR-155 to enhance CD8 T cell
responses. Although our observations suggest a connection be-
tween miR-155 and inflammatory and TCR signaling, precisely
how miR-155 integrates these events in TEX cells remains to be
determined.
In addition to these pathways, transcriptional profiling also
identified control of proliferation as a major change associated
with miR-155. These transcriptional data are consistent with
Ki67 staining and support a role for miR-155 in sustaining prolif-
eration. Specifically, miR-155 fostered greater expansion of
CD8 T cells and increased the numbers of TEX cell progenitors
and Ki67+ terminal TEX cells. Thus, these data suggest that
miR-155 enhances the number of TEX cell progenitors while
increasing the durability of terminal TEX cells. The increased
Ki67 in the terminal TEX cells might suggest a role for miR-155
in increasing the fraction of TEX cells that survive the proliferative
event in progenitor to terminal TEX cell conversion. This may
occur by increasing the frequency of this conversion without
eroding the progenitor pool or perhaps by directly inducing pro-
liferation in the terminal subset. Thus, miR-155 represents a cir-
cuit in the regulation of the balance and sustainability of TEX cell
subsets.
Our studies identified a mechanism for the AP-1 pathway in
regulating TEX cells. The AP-1 transcription factor complex con-
sists of heterodimers between members of the Jun family with
members of the Fos family or with members of the basic leucine
zipper ATF-like transcription factor (BATF) family. Fos family
members compete with BATF family members for binding to
Jun, JunB, and JunD (Murphy et al., 2013). AP-1 heterodimers
can then interact with other transcription factors, including
NFATs (Martinez et al., 2015) or IRF4 (Murphy et al., 2013).
BATF promotes T cell exhaustion, perhaps by interfering with ca-
nonical AP-1 function (Quigley et al., 2010). Moreover, at least
one key function of canonical Fos/Jun AP-1 dimers is to interact
with NFAT1 and NFAT2 and ensure the transcriptional program
of functionality. Indeed, partnerless NFAT working in the
absence of optimal AP-1 can drive TEX cell gene expressionhanges
5 OE-GFP RV and adoptively transferred to CD45.2+ recipient mice that were
T cells were isolated 30 d.p.i. by flow cytometry, and RNA-seq was performed.
in miR-155 OE GFP+ cells compared with control GFP+ cells and GFP cells,
e overlap between transcripts downregulated in miR-155 OE GFP+ cells and
SPONSE) in control GFP+ versus miR-155 OE GFP+ cells analyzed by GSEA.
nts downregulation in miR-155 OE cells compared with control GFP+ cells; red
AB
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Figure 7. Overexpression of Fosl2 Reverses the Effect of miR-155 Overexpression
CD45.1+ P14 CD8 T cells were co-transduced with a combination of two of the following RVs: empty-GFP (eGFP), empty-VEX (eVEX), miR-155 OE-GFP (miR),
and Fosl2-OE-VEX (Fosl2) and adoptively transferred to CD45.2 recipient mice that were infected 24 hr earlier with LCMV clone 13.
(A) Absolute numbers and phenotype of cells overexpressing miR-155 (identified as GFP+) were analyzed 30 d.p.i. in the spleen.
(legend continued on next page)
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(Martinez et al., 2015). Here we show that Fosl2 antagonizes
the effects of miR-155, suggesting a link in TEX cells between
miR-155 and the AP-1 transcriptional pathway through Fosl2.
miR-155 directly represses Fosl2 by binding to the 30 UTR
(Hu et al., 2014). By reducing the levels of Fosl2 in TEX cells,
miR-155 may increase the availability of Jun family members
for binding to BATF or other partners. Another possibility is
that, by downregulating Fosl2, miR-155 decreases the abun-
dance of canonical AP-1 dimers and increases the binding of
partnerless NFAT, which, in turn, promotes exhaustion (Martinez
et al., 2015). However, we also observed decreased NFAT1
(NFATc2) upon miR-155 overexpression, suggesting perhaps
an altered balance of NFAT1 and NFAT2 in addition to Fosl2
regulation. Interrogating the effects of altering the balance of
AP-1 family members as well as other partner transcription fac-
tors, such as NFATs and IRF4, will be an important future goal.
Overall, these data identify a key role for miR-155 in CD8 T cell
exhaustion. Through the study of the effects of miR-155, we
reveal two concepts with potential clinical implications. First,
we identify a key role for a member of the AP-1 family, Fosl2,
in regulating T cell exhaustion, suggesting that manipulating
the balance of AP-1 family members could be used to tune
T cell exhaustion clinically. Second, we reveal an opportunity
to sustain TEX cell populations long-term and increase the dura-
bility of this critical cell type through miR-155. Future work
exploring the manipulation of miR-155 could lead to approaches
that promote long-term persistence TEX cell populations or
adoptively transferred T cells in chronic infection or cancer.
EXPERIMENTAL PROCEDURES
Mice
Six- to eight-week-old male C57BL/6 (CD45.2) and C57BL/6 Ly5.2CR (CD45.1)
mice were purchased from National Cancer Institute (NCI). miR-155-deficient
(bic/miR-155/) mice were purchased from The Jackson Laboratory. TCR-
transgenic mice specific for the immunodominant LCMV Db-gp33-41 epitope
(P14 mice) on the C57BL/6 background were bred at the University of Pennsyl-
vania. Animal procedures were performed according to Institutional Animal
Care and Use Committee guidelines for the University of Pennsylvania.
Viral Infection and Calculation of Viral Loads
Mice were infected intravenously (i.v.) with 4 3 106 plaque-forming units
(PFUs) LCMV clone 13. For depletion of CD4 T cells, recipient mice were
injected twice with 200 mg anti-CD4 (GK1.5, Bio X Cell) intraperitoneally (i.p.)
at 1 day and +1 day of LCMV infection. For calculation of viral loads, tissues
were homogenized, and 10-fold dilutions were incubated on adherent Vero
cells for 1 hr. Cells were overlaid with a 1:1 mixture of medium and 1% agarose
and cultured for 4 days. Plaques (PFUs) were counted after overlaying with a
1:1:20 mixture of medium:1% agarose:neutral red for 16 hr.
Retroviral Experiments and Adoptive Transfers
miR-155 cDNA was cloned into the murine stem cell virus (MSCV)-internal
ribosomal entry site (IRES)-GFP plasmid as described previously (Gracias
et al., 2013). Themouse Fosl2 coding sequencewithout the 30 UTRwas cloned
into the MSCV-IRES-VEX plasmid. Empty MSCV-IRES-GFP or MSCV-IRES-(B) Absolute numbers and phenotype of cells overexpressing Fosl2 (identified as
(C) Absolute numbers and phenotype of cells overexpressing both miR-155 an
numbers in the flow plots indicate the mean ± SEM for all mice included in the a
Each data point represents an individual mouse. Representative data from three in
was calculated withMann-Whitney test (for A and B) or with Kruskal-Wallis test wit
data.mendeley.com/datasets/b7hkyjhvd6/1.
2154 Cell Reports 23, 2142–2156, May 15, 2018VEX plasmids were used as controls (Gracias et al., 2013). RV supernatants
were produced by transfecting 293T cells with an RV expression plasmid
and a pCl-Eco packaging plasmid using Lipofectamine 3000 (Invitrogen). For
RV transduction, CD8 T cells were purified from spleens of P14 mice using
the EasySep Mouse CD8+ T Cell Isolation Kit (STEMCELL Technologies)
and stimulated in vitro for 20 hr with 1 mg/mL soluble anti-CD3 (145-2C11,
BioLegend), 0.5 mg/mL anti-CD28 (37.51, BioLegend), and 100 U/mL recombi-
nant human IL-2 (PeproTech) as described previously (Kurachi et al., 2017).
Activated P14 cells were transduced with RV in the presence of Polybrene
(0.5 mg/mL) during spin infection (2,000 3 g for 60 min at 30C), as described
previously (Bengsch et al., 2016; Kurachi et al., 2017). Transduced P14 cells
were adoptively transferred i.v. into recipient mice that were infected 24 hr
earlier.
Flow Cytometry and Cell Sorting
Surface staining was performed in PBS containing 2% fetal bovine serum
(FBS) and 0.02% sodium azide using antibodies against CD8 (53-6.7,
BioLegend), CD45.1 (A20, BioLegend), CD45.2 (104, BioLegend), CD44
(IM7, BioLegend), KLRG1 (2F1/KLRG1), CD127 (A7R34, BioLegend),
CD62L (MEL-14, BioLegend), CD27 (LG.7F9, BioLegend), PD-1 (RMP1-30,
BioLegend), CD160 (7H1, BioLegend), and 2B4 (eBio244F4, eBioscience).
For staining for intracellular proteins, cells were fixed with fixation/permeabi-
lization buffer (eBioscience) and stained in permeabilization buffer
(eBioscience) with antibodies against Eomes (Dan11mag, eBioscience),
Ki67 (16A8, BioLegend), T-bet (4B10, BioLegend), and GFP (FM264G,
BioLegend). Intracellular cytokine staining was performed after 5 hr ex vivo
stimulation with gp33-41 peptide in the presence of GolgiPlug (Becton Dickin-
son), GolgiStop (BD), and anti-CD107a (1D4B, BioLegend) using antibodies
against TNF-a (MP6-XT22, BioLegend), IFN-g (XMG1.2, BD Pharmingen),
GzmB (GRB17, Life Technologies), MIP-1a (IC450P, R&D Systems), and
GFP (FM264G, BioLegend). Cells were analyzed using an LSRII (BD Biosci-
ences) and FlowJo software (Tree Star).
GFP+ and GFP P14 cells were sorted from splenocytes after surface
staining with CD8 (53-6.7, BioLegend), CD45.1 (A20, BioLegend), CD45.2
(104, BioLegend), and CD44 (IM7, BioLegend) for 30 min on ice. Cell sorting
was performed on Aria II (BD Biosciences).
qRT-PCR
Total RNAwas isolated using themiRNeasymini kit (QIAGEN).MousemiR-155
and snoRNA-429 (as an endogenous control) primers were from TaqMan (ABI
Biosciences). qRT-PCR was performed using iTaq Universal SybrGreen
Supermix from Bio-Rad on the ViiA 7 real-time PCR system according to the
manufacturer’s instructions.
RNA-Seq
RNA from sorted cells was isolated using RNA Plus Micro Kit (QIAGEN). Li-
braries were prepared using the SMARTer Ultra Low RNAKit (Clontech Labora-
tories) at the Next Generation Sequencing Core Facility at the University of
Pennsylvania (https://ngsc.med.upenn.edu/#/). Sequenced libraries were map-
ped to themm9 reference genome usingRNA-seq unifiedmapper (RUM) (Grant
et al., 2011). Read counts for NCBI Reference Sequence Database (RefSeq)
transcripts were processed with Deseq2 (Love et al., 2014). GSEA (Subrama-
nian et al., 2005) was performed using MSigDb (v5.1). The R package ‘‘pheat-
map’’ was used to create heatmaps. Significant genes were analyzed with
Metascape (http://metascape.org) for functional enrichment using ontology
terms collected from Gene Ontology (http://geneontology.org) for biological
processes. The upstream networks were generated through the use of
QIAGEN’s Ingenuity Pathway Analysis (IPA; QIAGEN, Redwood City; https://
www.qiagen.com/ingenuity).VEX+) were analyzed 30 d.p.i. in the spleen.
d Fosl2 (identified as GFP+VEX+) were analyzed 30 d.p.i. in the spleen. The
nalysis.
dependent experiments with at least 5 mice per group are shown. Significance
h Dunn’smultiple comparisons test (for C). Primary data are available at https://
Statistical Analysis
Normal distribution was tested using the D’Agostino and Pearson normality
test. For normally distributed samples, statistical significance was calculated
using unpaired two-tailed t test or one-way ANOVA (with Tukey’s multiple
comparisons test), as indicated. For non-normally distributed samples or sam-
ples too small to test for normal distribution, non-parametric Mann-Whitney
test or Kruskal-Wallis test (with Dunn’s multiple comparisons test) was per-
formed, as indicated.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and one table and can be
found with this article online at https://doi.org/10.1016/j.celrep.2018.04.038.
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